Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Clostridium perfringens CPE Polyclonal Antibody

Catalog #:   PXX12601 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P01558
Overview

Catalog No.

PXX12601

Species reactivity

Clostridium perfringens

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Clostridium perfringens CPE (Asp194-Ser305).

Target

Heat-labile enterotoxin B chain, cpe, Clostridium perfringens

Purification

Antigen affinity purification.

Accession

P01558

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CPE antibody (PXX12601) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 41 kDa
    Observed MW: 41 kDa
References

Clostridium butyricum: a promising approach to enhancing intestinal health in poultry., PMID:40470283

Humoral and cellular immune responses in cattle upon Clostridium chauvoei vaccination and challenge., PMID:40463373

Comparative evaluation of indirect-ELISAs based on native antigens of Clostridium chauvoei for the detection of blackleg-specific antibodies in cattle., PMID:40451457

Prevalence of epsilon toxin-producing Clostridium perfringens isolates among patients with multiple sclerosis and neuromyelitis optica spectrum disorder in Iran., PMID:40450217

Sheep immune response against a novel recombinant enterotoxemia and infectious necrotic hepatitis vaccine in Türkiye., PMID:40426194

Clostridium difficile as a potent trigger of colorectal carcinogenesis., PMID:40411629

Antibodies against Clostridium butyricum in the children of mothers at risk for gestational diabetes., PMID:40406906

Emphysematous rumenitis in a Japanese black calf caused by Clostridium perfringens with secondary Balantidium coli infection., PMID:40335292

Rational design and pairing of single-domain antibodies for developing rapid detection methods for botulinum neurotoxins A and B., PMID:40253065

Robust immune responses to intranasal vaccine targeting Bordetella pertussis antigens to claudin-4 on mucosal microfold cells., PMID:40220802

Fulminant Clostridioides difficile Infection: A Journey into the Unknown!, PMID:40185558

Effect of probiotics on immune cells in young Japanese Black calves responding to vaccination against bacterial respiratory diseases., PMID:40144064

Probiotic characterization, safety assessment, and production performance of a novel probiotic strain of Bacillus subtilis SKB/2074 (MCC 0563) in broiler chickens., PMID:40122117

Anti-interleukin-23 treatment linked to improved Clostridioides difficile infection survival., PMID:40114558

A simple cost-effective method for purification of Clostridium chauvoei cell-surface proteins for detection of antibodies against blackleg disease vaccine., PMID:40094060

Oral and parenteral vaccination of broiler chickens with Recombinant NetB antigen from Clostridium perfringens confers significant protection against necrotic enteritis., PMID:40087742

A novel single-domain antibody obtained from immune Bactrian camels against botulinum toxin type A using SPR-based screening method., PMID:40066047

IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity., PMID:40048372

Polymorphonuclear neutrophil depletion in ileal tissues reduces the immunopathology induced by Clostridioides difficile toxins., PMID:40023364

Dry and dusty outback: infant botulism., PMID:40000034

Risk factors and clinical characteristics of Clostridium difficile colonization and infection in patients with inflammatory bowel disease exposed to Vedolizumab: a multicenter retrospective study., PMID:39975482

Anti-IL-5 Treatment Reduces Infection-Related Adverse Events: A Meta-Analysis of Phase 3 Clinical Trials., PMID:39947298

Immunoprotective potential of egg yolk antibodies (IgYs) in controlling necrotic enteritis in broiler chickens., PMID:39919568

Immunogenicity of Type IV Pilin Proteins from Clostridium perfringens in Chickens., PMID:39858888

Does Clostridium Perfringens Epsilon Toxin Mimic an Auto-Antigen Involved in Multiple Sclerosis?, PMID:39852980

Development of a Recombinant Fusion Vaccine Candidate Against Lethal Clostridium botulinum Neurotoxin Types A and B., PMID:39852818

Oral Exposure to Clostridium difficile Toxin A Aggravates Food Allergy by Intestinal Barrier Destruction, Mast Cell Activation, and Th2-Biased Immune Responses., PMID:39847683

Development and selection of candidate monoclonal antibodies for the detection of Clostridium botulinum neurotoxin serotype B light chain., PMID:39755289

Clostridioides difficile binary toxin CDT induces biofilm-like persisting microcolonies., PMID:39719371

Structural insight into recognition of Clostridioides difficile toxin A by novel neutralizing nanobodies targeting QTIN-like motifs within its receptor-binding domain., PMID:39577542

The always evolving diagnosis and management of Clostridioides difficile colitis: What you need to know., PMID:39509684

A dual strain probiotic administered via the waterline beneficially modulates the ileal and cecal microbiome, sIgA and acute phase protein levels, and growth performance of broilers during a dysbacteriosis challenge., PMID:39504831

First case of infant botulism in Sicily-case report., PMID:39501395

Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study., PMID:39447053

Protection efficacy and immunogenicity of Clostridium chauvoei proteins as a subunit blackleg vaccine or an adjuvant for Clostridium perfringens epsilon toxoid., PMID:39395742

New Engineered-Chimeric Botulinum Neurotoxin Mutant Acts as an Effective Bivalent Vaccine Against Botulinum Neurotoxin Serotype A and E., PMID:39354747

Identification and preclinical evaluation of MMV676558 as a promising therapeutic candidate against Clostridioides difficile., PMID:39321508

Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E., PMID:39315101

Eosinophilic gastroenteritis-induced intestinal obstruction., PMID:39297613

Bacillary hemoglobinuria in beef cattle infected with Fascioloides magna in Missouri., PMID:39301884

Neutralization mechanism of human monoclonal antibodies against type B botulinum neurotoxin., PMID:39239735

Diagnosis and Management of Clostridioides difficile in Inflammatory Bowel Disease., PMID:39230037

Baseline Gut Microbiota Was Associated with Long-Term Immune Response at One Year Following Three Doses of BNT162b2., PMID:39204040

Select Gut Microbiota Impede Rotavirus Vaccine Efficacy., PMID:39179176

Production of highly soluble and immuno-reactive recombinant flagellin protein of Clostridium chauvoei., PMID:39142535

Is advanced age still a risk factor for recurrence of C. difficile infection in the era of new treatments?, PMID:39141079

Development of two recombinant vaccines against Clostridioides difficile infection and immunogenicity in pregnant sows and neonatal piglets., PMID:39127403

Immunogenicity of a pentavalent recombinant Escherichiacoli bacterin against enterotoxemia and botulism in sheep., PMID:39122140

Multiple Sclerosis and Clostridium perfringens Epsilon Toxin: Is There a Relationship?, PMID:39061966

Broiler chicken distal jejunum microbial communities are more responsive to coccidiosis or necrotic enteritis challenge than dietary anti-interleukin-10 in a model using Salmonella Typhimurium- Eimeria maxima- Clostridium perfringens coinfection., PMID:39002369

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Clostridium perfringens CPE Polyclonal Antibody [PXX12601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only